These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 22290080)

  • 1. Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.
    Girgert R; Emons G; Gründker C
    Breast Cancer Res Treat; 2012 Jul; 134(1):199-205. PubMed ID: 22290080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol.
    Girgert R; Emons G; Gründker C
    BMC Cancer; 2014 Dec; 14():935. PubMed ID: 25496649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib.
    Girgert R; Emons G; Gründker C
    Oncol Rep; 2017 Feb; 37(2):1212-1218. PubMed ID: 27959426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer.
    Mo Z; Liu M; Yang F; Luo H; Li Z; Tu G; Yang G
    Breast Cancer Res; 2013 Nov; 15(6):R114. PubMed ID: 24289103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
    Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
    Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A; Bonofiglio D; Recchia AG; Musti AM; Picard D; Andò S; Maggiolini M
    Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.
    Maggiolini M; Vivacqua A; Fasanella G; Recchia AG; Sisci D; Pezzi V; Montanaro D; Musti AM; Picard D; Andò S
    J Biol Chem; 2004 Jun; 279(26):27008-16. PubMed ID: 15090535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines.
    Fan P; McDaniel RE; Kim HR; Clagett D; Haddad B; Jordan VC
    Eur J Cancer; 2012 Dec; 48(18):3488-98. PubMed ID: 22658320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
    Filardo EJ; Quinn JA; Frackelton AR; Bland KI
    Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
    Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC
    Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of growth hormone receptor by Somavert reduces expression of GPER and prevents growth stimulation of triple-negative breast cancer by 17β-estradiol.
    Girgert R; Emons G; Gründker C
    Oncol Lett; 2018 Jun; 15(6):9559-9566. PubMed ID: 29805678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30.
    Vivacqua A; Bonofiglio D; Albanito L; Madeo A; Rago V; Carpino A; Musti AM; Picard D; Andò S; Maggiolini M
    Mol Pharmacol; 2006 Oct; 70(4):1414-23. PubMed ID: 16835357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
    Tsai CL; Wu HM; Lin CY; Lin YJ; Chao A; Wang TH; Hsueh S; Lai CH; Wang HS
    PLoS One; 2013; 8(9):e72999. PubMed ID: 24039841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.
    Albanito L; Sisci D; Aquila S; Brunelli E; Vivacqua A; Madeo A; Lappano R; Pandey DP; Picard D; Mauro L; Andò S; Maggiolini M
    Endocrinology; 2008 Aug; 149(8):3799-808. PubMed ID: 18467441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y; Birnbaumer L; Teng CT
    Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
    Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction Between CCL18 and GPR30 Differs from the Interaction Between Estradiol and GPR30.
    Schmidt-Wolf R; Zissel G
    Anticancer Res; 2020 Jun; 40(6):3097-3108. PubMed ID: 32487604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.
    Tian J; Wang Y; Zhang X; Ren Q; Li R; Huang Y; Lu H; Chen J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):153. PubMed ID: 29096683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.